Expert Q&A on Recent Developments with Orange Book-Listed Patent Challenges at the PTAB | Practical Law

Expert Q&A on Recent Developments with Orange Book-Listed Patent Challenges at the PTAB | Practical Law

An expert Q&A with Gregory A. Morris of Honigman Miller Schwartz and Cohn LLP on recent developments in Orange Book-listed patent challenges before the Patent Trial and Appeal Board (PTAB) under the Leahy-Smith America Invents Act (AIA). The Q&A discusses the success of these challenges to date, district courts' handling of motions to stay Hatch-Waxman litigation pending a PTAB challenge brought by an Abbreviated New Drug Application (ANDA) filer, and considerations for branded drug companies responding to these challenges.

Expert Q&A on Recent Developments with Orange Book-Listed Patent Challenges at the PTAB

by Practical Law Intellectual Property & Technology
Published on 23 Aug 2016 • USA (National/Federal)
An expert Q&A with Gregory A. Morris of Honigman Miller Schwartz and Cohn LLP on recent developments in Orange Book-listed patent challenges before the Patent Trial and Appeal Board (PTAB) under the Leahy-Smith America Invents Act (AIA). The Q&A discusses the success of these challenges to date, district courts' handling of motions to stay Hatch-Waxman litigation pending a PTAB challenge brought by an Abbreviated New Drug Application (ANDA) filer, and considerations for branded drug companies responding to these challenges.